Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 7.65 SEK -2.36% Market Closed
Market Cap: 366.3m SEK

Wall Street
Price Targets

MOB Price Targets Summary
Moberg Pharma AB (publ)

Wall Street analysts forecast MOB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOB is 11.22 SEK with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.

Lowest
Price Target
11.11 SEK
45% Upside
Average
Price Target
11.22 SEK
47% Upside
Highest
Price Target
11.55 SEK
51% Upside
Moberg Pharma AB (publ) Competitors:
Price Targets
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
36% Upside
6996
Antengene Corporation Ltd
47% Upside
300558
Betta Pharmaceuticals Co Ltd
15% Upside
NATCOPHARM
Natco Pharma Ltd
32% Upside
600079
Humanwell Healthcare Group Co Ltd
21% Upside
4746
Formosa Laboratories Inc
95% Upside
1666
Tong Ren Tang Technologies Co Ltd
36% Upside
600380
Joincare Pharmaceutical Group Industry Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Moberg Pharma AB (publ)

The compound annual growth rate of Moberg Pharma AB (publ)'s revenue for the next 3 years is 138%.

N/A
Past Growth
138%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Moberg Pharma AB (publ)

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Moberg Pharma AB (publ)

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOB's stock price target?
Price Target
11.22 SEK

According to Wall Street analysts, the average 1-year price target for MOB is 11.22 SEK with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.

What is Moberg Pharma AB (publ)'s Revenue forecast?
Projected CAGR
138%

The compound annual growth rate of Moberg Pharma AB (publ)'s revenue for the next 3 years is 138%.

Back to Top